5,7-dibromo-N-(p-methoxybenzyl)-isatin

ID: ALA395485

Chembl Id: CHEMBL395485

PubChem CID: 4730319

Max Phase: Preclinical

Molecular Formula: C16H11Br2NO3

Molecular Weight: 425.08

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CN2C(=O)C(=O)c3cc(Br)cc(Br)c32)cc1

Standard InChI:  InChI=1S/C16H11Br2NO3/c1-22-11-4-2-9(3-5-11)8-19-14-12(15(20)16(19)21)6-10(17)7-13(14)18/h2-7H,8H2,1H3

Standard InChI Key:  DTFUDRWQOPLJNB-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

U-937 (7138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARK7 Tbio Parkinson disease protein 7 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.08Molecular Weight (Monoisotopic): 422.9106AlogP: 3.95#Rotatable Bonds: 3
Polar Surface Area: 46.61Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.92CX LogD: 3.92
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.70Np Likeness Score: -0.61

References

1. Vine KL, Locke JM, Ranson M, Pyne SG, Bremner JB..  (2007)  An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.,  50  (21): [PMID:17887662] [10.1021/jm0704189]
2. Sabet R, Mohammadpour M, Sadeghi A, Fassihi A..  (2010)  QSAR study of isatin analogues as in vitro anti-cancer agents.,  45  (3): [PMID:20056518] [10.1016/j.ejmech.2009.12.010]
3. Matesic L, Locke JM, Vine KL, Ranson M, Bremner JB, Skropeta D..  (2011)  Synthesis and hydrolytic evaluation of acid-labile imine-linked cytotoxic isatin model systems.,  19  (5): [PMID:21306903] [10.1016/j.bmc.2011.01.015]
4. Maksimovic I, Finkin-Groner E, Fukase Y, Zheng Q, Sun S, Michino M, Huggins DJ, Myers RW, David Y..  (2021)  Deglycase-activity oriented screening to identify DJ-1 inhibitors.,  12  (7.0): [PMID:34355187] [10.1039/D1MD00062D]

Source